Document is current
Any future updates will be listed below
-
Authors
Iwahashi, Yasuyuki
Nishikage, Seiji
Hosokawa, Yusei
Yamada, Tomoko
Nakagawa, Yasushi
Hirota, Yushi
Sakaguchi, Kazuhiko
Nishimoto, Yuki
Nakajima, Shinsuke
Kitahama, Seiichi
Yamamoto, Yasuyoshi
Mukai, Tomoichiro
Ogawa, Wataru
Tamori, Yoshikazu https://orcid.org/0000-0003-3653-5683
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 6 February 2025
First Online: 8 April 2025
Declarations
:
: All the affiliations or financial involvement with any organization or financial conflict with the subject matter discussed in the manuscript are completely disclosed in this section. Yushi Hirota received lecture fees from Eli Lilly Japan K.K., Sanofi Aventis, Abbott Japan, Terumo Co., Novo Nordisk Pharma Ltd., and Sumitomo Pharma Co. Ltd. Yushi Hirota received a research funding from Sumitomo Pharma Co., Ltd., Medtronic Japan Co., Ltd., and Kyowa Kirin Co., Ltd. Yushi Hirota received a donation from Abbott Japan. Kazuhiko Sakaguchi received lecture fees from Sumitomo Pharma Co., Ltd., Novo Nordisk Pharma Ltd., Novartis Pharma K.K., Sanofi K.K., Eli Lilly Japan K.K., and MSD K.K. Kazuhiko Sakaguchi received a research grant from Sumitomo Pharma Co., Ltd. Wataru Ogawa received lecture fees from Sumitomo Pharma Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Abbott Japan, and Novo Nordisk Pharma Ltd. Wataru Ogawa received a research grant from Noster, Nippon Boehringer Ingelheim Co., Ltd., Boehringer Ingelheim Pharma GmbH and Co. KG, Co., Ltd., Eli Lilly Japan K.K., Sumitomo Pharma Co., Ltd., and Novo Nordisk Pharma Ltd. Wataru Ogawa received a donation from Sumitomo Pharma Co., Ltd. Yasuyuki Iwahashi, Seiji Nishikage, Yusei Hosokawa, Tomoko Yamada, Yasushi Nakagawa, Yuki Nishimoto, Shinsuke Nakajima, Seiichi Kitahama, Yasuyoshi Yamamoto, Tomoichiro Mukai, and Yoshikazu Tamori declare that they have no conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Study on the relationship between visceral adipose tissue insulin resistance and whole-body metabolism in individuals with severe obesity/May 24, 2023/B230036 and Observational study on changes in plasma lipid mediators in patients before and after bariatric surgery/May 2, 2023/20230502A) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.
